Fennec Pharmaceuticals (FENC) Financials

$10.64

$-0.08 (-0.75%)

As on 15-Sep-2026 16:00EDT

Market cap

$384 Mln

Revenue (TTM)

$59 Mln

P/E Ratio

--

P/B Ratio

9.3

Div. Yield

0 %

Annual
Quarterly

Cashflow ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Cash From Operating Activities	--	-12.47	26.98	-17.14	-18.06	-14.22
Cash Flow from Investing Activities	--	--	--	--	--	--
Cash from Financing Activities	--	22.63	-13.62	6.64	20.73	4.98
Net Cash Inflow / Outflow	--	--	--	--	--	-9.24

Financials Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Adjusted EPS ($)	-0.12	-0.31	-0.02	-0.60	-0.90	-0.67
Cash EPS ($)	--	-0.31	0.01	-0.59	-0.89	-0.67
Adjusted Book Value ($)	--	1.12	--	--	--	0.61
Dividend per Share ($)	--	--	--	--	--	--
Cash Flow per Share ($)	--	-0.40	0.98	-0.64	-0.69	-0.55
Free Cash Flow per Share ($)	--	-0.40	0.98	-0.64	-0.69	-0.55

Profitability Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
ROCE (%)	--	-40.15	-2.66	-77.02	-110.04	-69.60
ROE (%)	-8.35	-66.77	4.98	226.13	-359.22	-77.36
ROA (%)	-4.60	-16.94	-1.21	-59.64	-96.10	-64.45
EBIT Margin (%)	-4.19	-16.92	8.41	-59.53	-1,481.17	-10,138.82
Net Margin (%)	-5.49	-21.82	-0.92	-75.50	-1,544.89	-36,906.38
Cash Profit Margin (%)	0.00	--	--	--	--	--

Growth Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Revenue Growth (%)	77.83	-0.06	1.24	12.84	8.03	--
EBIT Growth (%)	70.81	-288.97	131.60	44.36	-31.91	6.84
Net Profit Growth (%)	72.99	-2,134.17	97.28	32.34	-36.71	4.21
EPS Growth (%)	73.38	-18.68	0.97	0.34	-0.35	0.13
Book Value Growth (%)	531.86	--	--	--	--	--

Valuation Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Price / Earnings	--	-24.64	-398.04	-18.76	-10.67	-6.60
Price / Book Value	9.34	6.85	-29.56	-25.90	-98.51	7.26
Dividend Yield (%)	--	--	--	--	--	--
EV/EBITDA	20.27	-27.28	34.65	-25.78	-11.25	-5.71
Close Price ($)	10.75	7.70	6.32	11.22	9.60	4.40
High Price ($)	11.31	9.92	11.49	11.92	10.38	10.08
Low Price ($)	5.65	4.68	3.96	6.30	4.11	3.82
Market Cap ($ Cr)	384.34	--	--	--	--	--

Solvency Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Debt to Equity	--	--	-3.29	-2.66	-9.69	0.32
Short term debt to equity ratio	--	--	0.00	0.00	--	0.00
Current Ratio	5.85	6.34	6.38	3.56	5.80	13.54
Quick Ratio	5.66	6.19	6.22	3.27	5.67	13.54
Interest Coverage	-2.43	-3.63	0.98	-3.73	-23.25	-136.79

Operating Efficiency Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Debtors to sales (%)	39.29	51.92	27.10	41.47	100.65	--
Asset Turnover	0.84	0.78	1.32	0.79	0.06	0.01
Receivable days	--	147.53	83.36	89.02	183.81	--
Inventory Days	--	127.22	184.46	396.29	1,223.16	--
Payable days	--	381.73	402.59	894.70	6,725.27	--
Cash Conversion Cycle	--	-106.97	-134.77	-409.39	-5,318.29	--

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.